RTW — RTW Biotech Opportunities Share News
0.000.00%
Last trade - 00:00- $725.25m
- $931.80m
- $34.57m
Brief: Aktis Announces $318 Million IPO
Brief: RTW Biotech Opportunities Announces New Investment In Yarrow Bioscience
RTW Biotech Opp. - Monthly Valuation Update and Factsheet
Brief: RTW Biotech Opportunities Joins FTSE 250 Index
Brief: RTW Biotech Opportunities Reports Unaudited NAV Attributable To Ordinary Shares As At 31 Oct $2.37 Per Share
RTW Biotech Opp. - Monthly Valuation Update and Factsheet
RTW Biotech Opp. - Holding(s) in Company
Brief: RTW Biotech Opportunities Says Savara Announces $75m Funding Agreement With Co
RTW Biotech Opp. - Royalty Funding Agreement with Savara Inc.
Brief: RTW Biotech Opportunities Ltd Says Novartis To Acquire Avidity Biosciences
RTW Biotech Opp. - Monthly Valuation Update and Factsheet
RTW Biotech Opp. - Genmab to acquire Merus
Brief: RTW Biotech Annonuces Biogen To Acquire Alcyone Therapeutics
RTW Biotech Opp. - Biogen to acquire Alcyone Therapeutics
RTW Biotech Opp. - Half-year Report
RTW Biotech Opp. - Inclusion in FTSE All-Share Index
RTW Biotech Opp. - Notice of Interim Results
RTW Biotech Opp. - Strategic Funding Agreement with Aquestive
RTW Biotech Opp. - Monthly Valuation Update and Factsheet